SCHEMBL4841967

SCHEMBL4841967

CCOC(=O)Nc1ccc(C(=O)C=C2NC(C)(C)Cc3ccc(OC)cc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
LMNA P02545 2/20 0.49
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C19 P33261 3/20 0.47
HPGD P15428 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
GAA P10253 1/20 0.47
MTNR1B P49286 2/20 0.44
MTNR1A P48039 1/20 0.41
MAPT P10636 6/20 0.41
RAB9A P51151 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KCNQ2 O43526 1/20 0.39
TNF P01375 1/20 0.39
NPC1 O15118 3/20 0.39
HTT P42858 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841954 1.00 KDM4E (0.49) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4835307 0.93 LMNA (0.43) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4835291 0.93 LMNA (0.43) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4839999 0.93 KDM4E (0.42) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4839986 0.93 KDM4E (0.42) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4844868 0.92 RAB9A (0.47) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4844881 0.92 RAB9A (0.47) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4839126 0.91 KDM4E (0.41) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4839143 0.91 KDM4E (0.41) KDM4ELMNAALDH1A1CYP1A2CYP3A4
SCHEMBL4844899 0.91 LMNA (0.48) KDM4ELMNAALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 KDM4E 4466/4885LMNA 3014/4885ALDH1A1 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.